Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| MoonLake Immunotherapeutics | 520,342 | reported | 07 Jan 2026 | tx 20+3,979,975−3,848,610 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 07 Jan 2026 | GRANT_AWARD | MoonLake Immunotherapeutics | 520,342 | 0.00 USD | deriv |
| 19 Dec 2025 | OTHER | MoonLake Immunotherapeutics | 196,316 | — | |
| 19 Dec 2025 | CONVERSION | MoonLake Immunotherapeutics | 196,316 | — | |
| 19 Dec 2025 | CONVERSION | MoonLake Immunotherapeutics | 5,836 | — | deriv |
| 09 Dec 2025 | SALE | MoonLake Immunotherapeutics | 70,000 | 14.49 USD | |
| 08 Dec 2025 | SALE | MoonLake Immunotherapeutics | 130,000 | 15.08 USD | |
| 27 Feb 2025 | GRANT_AWARD | MoonLake Immunotherapeutics | 95,763 | 0.00 USD | |
| 29 Feb 2024 | SALE | MoonLake Immunotherapeutics | 4,740 | 55.89 USD | |
| 28 Feb 2024 | SALE | MoonLake Immunotherapeutics | 56,065 | 55.00 USD | |
| 27 Feb 2024 | SALE | MoonLake Immunotherapeutics | 62,810 | 55.00 USD | |
| 21 Feb 2024 | SALE | MoonLake Immunotherapeutics | 1,125 | 55.27 USD | |
| 15 Feb 2024 | SALE | MoonLake Immunotherapeutics | 20,000 | 60.18 USD | |
| 20 Feb 2024 | SALE | MoonLake Immunotherapeutics | 20,000 | 57.44 USD | |
| 16 Feb 2024 | SALE | MoonLake Immunotherapeutics | 20,000 | 60.15 USD | |
| 01 Oct 2023 | CONVERSION | MoonLake Immunotherapeutics | 140,071 | — | |
| 01 Oct 2023 | OTHER | MoonLake Immunotherapeutics | 3,027,483 | — | |
| 01 Oct 2023 | CONVERSION | MoonLake Immunotherapeutics | 3,027,483 | — | |
| 01 Oct 2023 | OTHER | MoonLake Immunotherapeutics | 140,071 | — | |
| 01 Oct 2023 | CONVERSION | MoonLake Immunotherapeutics | 90,000 | — | deriv |
| 01 Oct 2023 | CONVERSION | MoonLake Immunotherapeutics | 4,164 | — | deriv |